<DOC>
	<DOCNO>NCT00971048</DOCNO>
	<brief_summary>To compare HP828-101 standard care management partial full thickness wound</brief_summary>
	<brief_title>Evaluation Effects HP828-101 Versus Standard Care Management Partial Full Thickness Wounds</brief_title>
	<detailed_description>The primary objective compare HP828-101 standard care management partial full thickness wound , evaluate use Bates Jensen Wound Assessment Tool ( BWAT ) . The secondary objective comparison proportion subject wound closure day 22 , comparison pain assess use visual analog scale ( VAS ) , evaluation moist wound environment per BWAT .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<criteria>The informed consent document must read , sign , date subject subject 's legally authorize representative conduct study procedure exams . In addition , informed consent document must sign date individual consent subject conduct Visit 1 . A photocopy sign informed consent document must provide subject , original sign document place subject 's chart . For subject agree wound photographed trial , photo release consent form must sign documented well . Age 18 year old , either sex , race skin type , provide skin color , opinion Investigator , interfere study assessment . Females , childbearing potential , negative urine pregnancy test agree use acceptable contraception study . Adequate birth control method define : hormonal—topical , oral , implantable , injectable contraceptive ; mechanical—spermicide conjunction barrier condom diaphragm ; IUD ; surgical sterilization partner . Have partial full thickness PU foot ankle DFU &lt; = 6 month duration ≥1.0 ≤ 12.0 cm² area . Are willing make require study visit . Are willing follow instruction , opinion Investigator . Have , within 12 week prior randomization , serum albumin level ≥ 2.0 g/dL ( 20 g/L ) ; Alkaline phosphatase , AST , ALT , serum creatinine , BUN level &lt; 3 x upper limit normal ; HbA1C ≤ 12 % ; Hemoglobin &gt; = 8 g/dL . The recently obtain value must evaluate criterion . Please refer Appendix 18.1.5 Have arterial supply adequacy confirm Ankle Brachial Index ( ABI ) &gt; = 0.7 ≤ 1.1 ABI &gt; 1.1 , either TcPO2 &gt; = 40 mmHg , measured foot , great toe pressure ≥ 50 mm/Hg , For ulcer require surgical debridement prior enrollment , wound must expect remain partial thickness wound debridement . Have know hypersensitivity test article component . Have receive therapy another investigational agent within thirty ( 30 ) day Visit 1 . Are pregnant nursing . Have clinical evidence bacterial fungal infection wound per visual/clinical assessment . Have severe burn , immunodeficiency disorder , hematologic disorder , metastatic malignancy . Have document osteomyelitis target ulcer leg within 6 month precede screen visit . Have severe edema target ulcer leg . If treated Xenaderm , must stop treatment prior enrol study . Have receive treatment glucocorticoid &gt; 10 consecutive day within 6 month prior start study . Have receive chemotherapy radiation therapy within past 5 year . Therapy target ulcer tissueengineered cellbased skin equivalent within 30 day precede Screening Visit ( e.g. , Apligraf® ) . Therapy target ulcer topical growth factor within 1 week precede Screening Visit . Current therapy systemic topical antibiotic systemic therapy cytotoxic drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>pressure ulcer</keyword>
	<keyword>PU</keyword>
	<keyword>diabetic foot ulcer</keyword>
	<keyword>DFU</keyword>
	<keyword>Bates-Jensen Wound Assessment</keyword>
</DOC>